We are live on ! Find out more
VCM

Versant Capital Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
+8.5%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.66%
AUM
$335M
AUM Growth
+$20.7M
Cap. Flow
-$3.47M
Cap. Flow %
-1.03%
Top 10 Hldgs %
51.32%
Holding
2,051
New
113
Increased
498
Reduced
755
Closed
137
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBIX
2051
DELISTED
Ebix Inc
EBIX
-583
Closed -$5.76K

Similar funds

Versant Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Versant Capital Management held 2,051 positions worth $335M, up 6.6% from $315M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Versant Capital Management's Q4 2023 filing shows 113 new, 498 increased, 755 reduced and 137 closed positions. Its largest new stake was Vanguard Short-Term Inflation-Protected Securities Index Fund: 2,200 shares worth $104K. The largest sale was Tenet Healthcare, an estimated $2.35M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 6.6% a quarter earlier, followed by Financials and Energy.

  • Versant Capital Management's largest Q4 2023 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 2,200 shares worth $104K.
  • Versant Capital Management added most to Vanguard Emerging Markets Government Bond ETF in Q4 2023, an estimated $658K increase.
  • Versant Capital Management's biggest Q4 2023 reduction was CSG Systems International, cutting an estimated $1.95M.
  • Versant Capital Management fully exited Tenet Healthcare in Q4 2023, selling an estimated $2.35M.
  • Versant Capital Management's ten largest holdings make up 51% of its $335M portfolio in Q4 2023.
  • Versant Capital Management opened 113 new positions and closed 137 in Q4 2023.
  • Versant Capital Management's portfolio value rose 6.6% quarter-over-quarter to $335M.

Based on Versant Capital Management's 13F filing for Q4 2023, filed 8 Jan 2024.